iTRAQ-based Proteomics Analysis of ADTM for Preventing the Development of Nitroglycerin-induced Tolerance
- 31 August 2022
- journal article
- research article
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 18 (9) , 892-900
Abstract
Background: Long-term nitroglycerin (NTG) therapy causes tolerance, which limits its clinical application. Previous studies have reported a novel Danshensu/tetramethylpyrazine derivative ADTM, which displays strong cardioprotective effects. However, the effect of ADTM is not known in the NTGinduced tolerance model. In this study, we aimed to evaluate the potential improvement and underlying mechanism of ADTM for preventing the development of NTG-induced tolerance in in vivo and in vitro experiments. Methods: Firstly, the effect of ADTM was determined on NTG-induced tolerance using isolated thoracic aortic rings obtained from rats (50 μM for 45 min). After intragastric administration of ADTM (30 mg/kg, twice a day) for 7 days, NTG solution (10 mg/kg) was subcutaneously injected into male Sprague-Dawley (SD) rats once a day for 7 consecutive days. The systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and mean arterial pressure (MAP) were recorded using the PowerLab system. The iTRAQ-based proteomics analysis was used to clarify the underlying mechanism of ADTM in NTG-induced tolerance. Results: ADTM markedly enhanced relaxation sensitivity and vasodilator responses to NTG tolerance in the isolated rat thoracic aorta, and this effect was independent of the vascular endothelium. ADTM prevented the development of NTG-induced tolerance in rats by improving hemodynamic parameters, such as SAP, DAP, and MAP. The iTRAQ-based proteomic analysis suggests that ADTM prevention of NTGinduced tolerance may be related to the regulation of ribosomal metabolism and tight junctions. Conclusion: These results indicate that ADTM has therapeutic potential for NTG-induced tolerance, and is worthy of further studies.Keywords
Funding Information
- National Natural Science Foundation of China (82003726, 82104135)
- Scientific Projects of Guangdong Province (2019A1515110751)
- Guangdong Research and Development project (2020A1515111207)
This publication has 38 references indexed in Scilit:
- Nitrate TherapyCirculation, 2011
- Vascular tolerance to nitroglycerin in ascorbate deficiency: results are in favour of an important role of oxidative stress in nitrate toleranceCardiovascular Research, 2008
- Danshen: What every cardiologist should know about this Chinese herbal drugInternational Journal of Cardiology, 2006
- Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyEuropean Heart Journal, 2006
- Explaining the Phenomenon of Nitrate ToleranceCirculation Research, 2005
- Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerancePharmacology & Therapeutics, 2005
- Roles of Superoxide, Peroxynitrite, and Protein Kinase C in the Development of Tolerance to NitroglycerinThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.Journal of Clinical Investigation, 1995
- Nitrate toleranceInternational Journal of Cardiology, 1986
- Nitrate toleranceAmerican Heart Journal, 1985